by Eric Christianson | Jan 12, 2025 | Endocrine Medication and Disease State Clinical Pearls
Treating patients with type II diabetes often requires an array of medications to control blood sugar and manage various comorbidities. Understanding possible drug-drug and drug-disease interactions between medications is extremely important for optimizing medication...
by Eric Christianson | Dec 29, 2024 | Endocrine Medication and Disease State Clinical Pearls
Reducing diabetes medications in geriatric patients with low A1c involves careful consideration of the risks and benefits of continued intensive glycemic control. In older adults, particularly those with multiple comorbidities, frailty, or limited life expectancy,...
by Eric Christianson | Nov 24, 2024 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls
Insulin icodec may have a new competitor in the near future. Insulin efsitora is another once-weekly insulin currently undergoing phase 3 clinical trials, with Lilly’s 3rd phase being termed the QWINT trials (Once Weekly (QW) Insulin Therapy (INT)). These trials are...
by Eric Christianson | Sep 22, 2024 | Endocrine Medication and Disease State Clinical Pearls
Fluctuations in blood sugars can be very distressing for patients. This is especially true in patients who have adequate control of their diabetes. Adverse effects can lead to an escalation of diabetes medication. I’ll share my top 5 drugs that cause...
by Eric Christianson | Mar 10, 2024 | Endocrine Medication and Disease State Clinical Pearls
For individuals with type 2 diabetes taking insulin, managing doses is a critical aspect of their treatment regimen. Proper management of insulin doses can help maintain blood sugar levels within a healthy range and prevent complications associated with high or low...
